Matches in SemOpenAlex for { <https://semopenalex.org/work/W2555996664> ?p ?o ?g. }
- W2555996664 endingPage "9813" @default.
- W2555996664 startingPage "9813" @default.
- W2555996664 abstract "To investigate the association between interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) polymorphisms and interferon-α (IFNα) treatment efficiency among Chinese hepatitis B virus (HBV) infection patients.Two hundred and twenty five newly diagnosed chronic hepatitis B (CHB) patients were enrolled in the study. All of these patients received IFNα treatment for a course of 48 wk, and were followed up for 24 wk after the treatment was end. Clinical information about virological response, hepatitis B e antigen (HBeAg) seroconversion rate and combined response at the end of the treatment, as well as the sustained response by the time of following up 24 wk after the treatment, was collected. Four tag-single nucleotide polymorphisms (SNPs) of IFIT1 were selected and assessed for their association with these clinical outcomes.At the end of the treatment, HBeAg seroconversion was observed in 27.1% patients. Thirty-six point nine percent patients achieved virological response, and 15.6% patients exhibited combined response. Sustained response was obtained in 26.2% patients. The main HBV genotype of the study was genotype B. Patients who infected with HBV genotype B or C showed better treatment efficiency, no matter which clinical outcome was considered. Among the four SNPs assessed, rs303218 (A > G) was found to be significantly associated with the end point virological response when assuming additive model [OR = 0.64 (95%CI: 0.42-0.96), P = 0.032]. Patients who carried rs303218 GG genotype had a rather higher rate of achieving virological response (response rate: 52%, OR = 0.40, 95%CI: 0.18-0.91; P = 0.028) when compared to those had AA genotype (response rate: 27%). The most significant interaction was observed in patients who had relative lower baseline aspartate transaminase. No association between SNPs and HBeAg seroconversion, combined response or sustained response was observed.IFIT1 involves in the regulation of IFNα treatment for CHB and its polymorphism rs303218 can predict the end point virological response. The finding requires further validation." @default.
- W2555996664 created "2016-11-30" @default.
- W2555996664 creator A5000617779 @default.
- W2555996664 creator A5007991562 @default.
- W2555996664 creator A5015302417 @default.
- W2555996664 creator A5015488433 @default.
- W2555996664 creator A5041812006 @default.
- W2555996664 creator A5046280183 @default.
- W2555996664 creator A5050279633 @default.
- W2555996664 creator A5051153879 @default.
- W2555996664 creator A5063412345 @default.
- W2555996664 creator A5068255173 @default.
- W2555996664 creator A5068385134 @default.
- W2555996664 creator A5083301457 @default.
- W2555996664 date "2016-01-01" @default.
- W2555996664 modified "2023-10-18" @default.
- W2555996664 title "<i>IFIT1</i>polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection" @default.
- W2555996664 cites W1964271390 @default.
- W2555996664 cites W1965228865 @default.
- W2555996664 cites W1969264016 @default.
- W2555996664 cites W1973530869 @default.
- W2555996664 cites W2004727967 @default.
- W2555996664 cites W2004832653 @default.
- W2555996664 cites W2006940895 @default.
- W2555996664 cites W2007888457 @default.
- W2555996664 cites W2009399652 @default.
- W2555996664 cites W2014176574 @default.
- W2555996664 cites W2024041718 @default.
- W2555996664 cites W2025890951 @default.
- W2555996664 cites W2028876212 @default.
- W2555996664 cites W2031913105 @default.
- W2555996664 cites W2036706445 @default.
- W2555996664 cites W2038459819 @default.
- W2555996664 cites W2040167513 @default.
- W2555996664 cites W2044818544 @default.
- W2555996664 cites W2050843600 @default.
- W2555996664 cites W2051417669 @default.
- W2555996664 cites W2055043707 @default.
- W2555996664 cites W2056132396 @default.
- W2555996664 cites W2058492139 @default.
- W2555996664 cites W2067108722 @default.
- W2555996664 cites W2076039408 @default.
- W2555996664 cites W2079006974 @default.
- W2555996664 cites W2084332699 @default.
- W2555996664 cites W2089008855 @default.
- W2555996664 cites W2107779325 @default.
- W2555996664 cites W2110162135 @default.
- W2555996664 cites W2114323093 @default.
- W2555996664 cites W2114599219 @default.
- W2555996664 cites W2122749974 @default.
- W2555996664 cites W2124193538 @default.
- W2555996664 cites W2126586870 @default.
- W2555996664 cites W2133402546 @default.
- W2555996664 cites W2150408070 @default.
- W2555996664 cites W2150600194 @default.
- W2555996664 cites W2164547320 @default.
- W2555996664 cites W2167744756 @default.
- W2555996664 cites W2170973430 @default.
- W2555996664 cites W2171578784 @default.
- W2555996664 cites W2233586200 @default.
- W2555996664 cites W752812315 @default.
- W2555996664 doi "https://doi.org/10.3748/wjg.v22.i44.9813" @default.
- W2555996664 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5124986" @default.
- W2555996664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27956805" @default.
- W2555996664 hasPublicationYear "2016" @default.
- W2555996664 type Work @default.
- W2555996664 sameAs 2555996664 @default.
- W2555996664 citedByCount "8" @default.
- W2555996664 countsByYear W25559966642019 @default.
- W2555996664 countsByYear W25559966642020 @default.
- W2555996664 countsByYear W25559966642021 @default.
- W2555996664 countsByYear W25559966642022 @default.
- W2555996664 countsByYear W25559966642023 @default.
- W2555996664 crossrefType "journal-article" @default.
- W2555996664 hasAuthorship W2555996664A5000617779 @default.
- W2555996664 hasAuthorship W2555996664A5007991562 @default.
- W2555996664 hasAuthorship W2555996664A5015302417 @default.
- W2555996664 hasAuthorship W2555996664A5015488433 @default.
- W2555996664 hasAuthorship W2555996664A5041812006 @default.
- W2555996664 hasAuthorship W2555996664A5046280183 @default.
- W2555996664 hasAuthorship W2555996664A5050279633 @default.
- W2555996664 hasAuthorship W2555996664A5051153879 @default.
- W2555996664 hasAuthorship W2555996664A5063412345 @default.
- W2555996664 hasAuthorship W2555996664A5068255173 @default.
- W2555996664 hasAuthorship W2555996664A5068385134 @default.
- W2555996664 hasAuthorship W2555996664A5083301457 @default.
- W2555996664 hasBestOaLocation W25559966641 @default.
- W2555996664 hasConcept C104317684 @default.
- W2555996664 hasConcept C126322002 @default.
- W2555996664 hasConcept C135763542 @default.
- W2555996664 hasConcept C153209595 @default.
- W2555996664 hasConcept C159047783 @default.
- W2555996664 hasConcept C203014093 @default.
- W2555996664 hasConcept C2522874641 @default.
- W2555996664 hasConcept C2775940106 @default.
- W2555996664 hasConcept C2776178377 @default.
- W2555996664 hasConcept C2777410769 @default.
- W2555996664 hasConcept C2777451964 @default.